Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis

OBJECTIVES: Clinicians concerned about long-term safety of biologics in JIA may consider tapering or stopping treatment once remission is achieved despite uncertainty in maintaining drug-free remission. This analysis aims to (i) calculate how many patients with JIA stop biologics for remission, (ii)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearsley-Fleet, Lianne, Baildam, Eileen, Beresford, Michael W, Douglas, Sharon, Foster, Helen E, Southwood, Taunton R, Hyrich, Kimme L, Ciurtin, Coziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152290/
https://www.ncbi.nlm.nih.gov/pubmed/36104094
http://dx.doi.org/10.1093/rheumatology/keac463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152290/
https://www.ncbi.nlm.nih.gov/pubmed/36104094
http://dx.doi.org/10.1093/rheumatology/keac463

Ejemplares similares